GA
ACHC icon

Geneva Advisors’s Acadia Healthcare ACHC Stock Holding History

Geneva Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.35M Buy
67,810
+6,890
+11% +$305K 0.06% 149
2017
Q1 		$2.66M Sell
60,920
-1,980
-3% -$80.3K 0.05% 177
2016
Q4 		$2.08M Sell
62,900
-468,120
-88% -$18.2M 0.04% 201
2016
Q3 		$26.3M Sell
531,020
-56,405
-10% -$2.94M 0.49% 61
2016
Q2 		$32.5M Sell
587,425
-209,073
-26% -$12.2M 0.64% 57
2016
Q1 		$43.9M Sell
796,498
-31,204
-4% -$1.78M 0.88% 43
2015
Q4 		$51.7M Sell
827,702
-2,349
-0.3% -$153K 0.99% 32
2015
Q3 		$55M Buy
830,051
+27,405
+3% +$2.11M 1.11% 31
2015
Q2 		$62.9M Sell
802,646
-134,101
-14% -$9.65M 1.12% 34
2015
Q1 		$67.1M Sell
936,747
-12,658
-1% -$812K 1.21% 29
2014
Q4 		$58.1M Sell
949,405
-38,175
-4% -$2.22M 1.08% 35
2014
Q3 		$47.9M Sell
987,580
-66,819
-6% -$3.27M 0.9% 45
2014
Q2 		$48M Sell
1,054,399
-292,544
-22% -$12.9M 0.87% 44
2014
Q1 		$60.8M Buy
1,346,943
+8,941
+0.7% +$441K 1.12% 33
2013
Q4 		$63.3M Buy
1,338,002
+27,580
+2% +$1.2M 1.17% 32
2013
Q3 		$51.7M Buy
1,310,422
+27,206
+2% +$1.01M 1.07% 33
2013
Q2 		$42.4M Buy
+1,283,216
New +$41.6M 0.99% 41

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geneva Advisors's ACHC Position: Q2 2017 in Review

Geneva Advisors increased its Acadia Healthcare (ACHC) stake by 11% in Q2 2017, buying an estimated $305K and bringing the position to 67,810 shares worth $3.35M. The position accounts for 0.06% of the portfolio, ranked #149.

Geneva Advisors first reported a position in ACHC in Q2 2013 and has held it in 17 quarters since. The position peaked at $67.1M in Q1 2015. 249 funds tracked by Wall St. Rank hold ACHC as of Q2 2017.

  • Geneva Advisors held 67,810 shares of Acadia Healthcare worth $3.35M as of Q2 2017.
  • Geneva Advisors bought 6,890 Acadia Healthcare shares in Q2 2017, an estimated $305K.
  • Acadia Healthcare made up 0.06% of Geneva Advisors's portfolio in Q2 2017, its #149 holding.
  • Geneva Advisors first reported a position in Acadia Healthcare in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Acadia Healthcare position peaked at $67.1M in Q1 2015.
  • 249 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.